Eris Lifesciences Q1 FY26: Why This Pharma Stock Is Primed for Explosive Growth Amidst Market Volatility

Amidst broader market corrections, Eris Lifesciences’ Q1 FY26 results stand out. Discover how …

Aug 16, 2025 16:36

Nuvama Q1 FY26 Earnings: Is This Financial Powerhouse Set to Become India's Next 'Super Grower'?

Dive into Nuvama’s Q1 FY26 earnings report to understand how this financial services firm …

Aug 16, 2025 15:26